STIFEL FINANCIAL CORP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$430,166
+4.8%
4,802
-0.4%
0.00%0.0%
Q2 2023$410,373
+1.4%
4,820
-1.5%
0.00%0.0%
Q1 2023$404,736
+7.8%
4,891
+2.5%
0.00%0.0%
Q4 2022$375,320
+3.7%
4,772
-2.4%
0.00%0.0%
Q3 2022$362,000
-21.0%
4,887
-30.4%
0.00%0.0%
Q2 2022$458,000
-20.3%
7,025
-22.8%
0.00%0.0%
Q1 2022$575,000
+20.5%
9,096
+1.1%
0.00%0.0%
Q4 2021$477,000
-47.2%
8,995
-29.8%
0.00%0.0%
Q3 2021$904,000
-46.9%
12,810
-49.8%
0.00%
-66.7%
Q2 2021$1,701,000
-28.5%
25,516
+19.0%
0.00%
-25.0%
Q1 2021$2,380,000
-6.1%
21,434
+0.4%
0.00%
-20.0%
Q4 2020$2,535,000
+43.1%
21,352
+5.1%
0.01%
+25.0%
Q3 2020$1,772,000
+170.5%
20,308
+177.8%
0.00%
+100.0%
Q2 2020$655,000
+50.9%
7,311
+68.4%
0.00%
+100.0%
Q1 2020$434,000
-45.3%
4,341
-37.5%
0.00%
-50.0%
Q4 2019$793,000
-17.7%
6,944
-8.7%
0.00%0.0%
Q3 2019$964,000
+159.8%
7,605
+146.6%
0.00%
+100.0%
Q2 2019$371,000
-42.5%
3,084
-58.4%
0.00%
-50.0%
Q1 2019$645,000
-25.2%
7,406
-13.4%
0.00%
-33.3%
Q4 2018$862,000
+116.0%
8,550
+145.7%
0.00%
+200.0%
Q3 2018$399,000
-65.2%
3,480
-72.8%
0.00%
-75.0%
Q2 2018$1,145,000
+23.3%
12,780
+1.0%
0.00%
+33.3%
Q1 2018$929,000
+26.9%
12,657
+0.3%
0.00%
+50.0%
Q4 2017$732,000
+27.5%
12,614
-1.4%
0.00%0.0%
Q3 2017$574,000
+22.1%
12,791
+7.3%
0.00%0.0%
Q2 2017$470,000
+25.0%
11,924
+28.9%
0.00%
+100.0%
Q1 2017$376,000
+1.1%
9,249
-0.5%
0.00%
-50.0%
Q4 2016$372,000
-18.6%
9,297
-26.2%
0.00%0.0%
Q3 2016$457,000
-6.0%
12,596
-24.8%
0.00%0.0%
Q2 2016$486,000
-21.0%
16,748
-4.9%
0.00%
-33.3%
Q1 2016$615,000
+5.5%
17,605
-2.8%
0.00%0.0%
Q4 2015$583,000
+2.8%
18,108
+3.4%
0.00%0.0%
Q3 2015$567,000
-58.7%
17,513
-47.1%
0.00%
-25.0%
Q2 2015$1,372,000
+114.7%
33,110
+133.0%
0.00%
+33.3%
Q1 2015$639,000
+138.4%
14,213
+98.6%
0.00%
+200.0%
Q4 2014$268,000
+4.7%
7,158
-2.4%
0.00%
-50.0%
Q3 2014$256,0007,3340.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders